Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Adma Biologics (ADMA) Tax Provisions (2024 - 2025)

Adma Biologics (ADMA) has disclosed Tax Provisions for 4 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Tax Provisions rose 101.55% year-over-year to $1.2 million, compared with a TTM value of $24.7 million through Dec 2025, up 134.33%, and an annual FY2025 reading of $24.7 million, up 134.33% over the prior year.
  • Tax Provisions was $1.2 million for Q4 2025 at Adma Biologics, down from $11.1 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $11.1 million in Q3 2025 and bottomed at -$77.2 million in Q4 2024.